| abstract |
A therapeutic or prophylactic treatment of ischemia, such as due to myocardial infarction, by administering thrombopoietin alone or in combination with other agents to a patient suffering from or at risk for cardiac injury such as myocardial ischemia. Thrombopoietin is administered at a concentration such that the subject's total platelet count or platelet production is not significantly affected. |